Mankind Pharma allotted 80,872 equity shares under its 2022 ESOP plan following option exercises by an employee.
The allotment increased the company's paid-up share capital from 412.83 million to 412.91 million shares.
Shares were issued at two different exercise prices: ₹860 for 73,372 shares and ₹1,600 for 7,500 shares.
The newly issued shares will rank pari-passu with existing equity shares of the company.